Market closedNon-fractional

Crinetics Pharmaceuticals/CRNX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ticker

CRNX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Diego, United States

Employees

290

CRNX Metrics

BasicAdvanced
$3.6B
Market cap
-
P/E ratio
-$3.76
EPS
0.63
Beta
-
Dividend rate
$3.6B
0.63
17.718
17.584
5.339
6.001
-24.01%
-40.76%
1,445.71
4.08
4.08
-15.47
-53.93%
14.98%
15.62%

What the Analysts think about CRNX

Analyst Ratings

Majority rating from 14 analysts.
Buy

CRNX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-11,150.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$600K
∞%
Net income
-$67M
11.50%
Profit margin
-11,150.00%
-∞%

CRNX Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.90%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.94
-$1.01
-$0.90
-$0.93
-
Expected
-$0.86
-$0.86
-$0.86
-$0.81
-$0.86
Surprise
9.61%
17.59%
4.36%
14.90%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Crinetics Pharmaceuticals stock?

Crinetics Pharmaceuticals (CRNX) has a market cap of $3.6B as of July 04, 2024.

What is the P/E ratio for Crinetics Pharmaceuticals stock?

The price to earnings (P/E) ratio for Crinetics Pharmaceuticals (CRNX) stock is 0 as of July 04, 2024.

Does Crinetics Pharmaceuticals stock pay dividends?

No, Crinetics Pharmaceuticals (CRNX) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Crinetics Pharmaceuticals dividend payment date?

Crinetics Pharmaceuticals (CRNX) stock does not pay dividends to its shareholders.

What is the beta indicator for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (CRNX) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Crinetics Pharmaceuticals stock

Buy or sell Crinetics Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing